The official Ukraine crypto wallets are now accepting donations from the Polkadot (DOT) ecosystem; cofounder Gavin Wood has donated $5.8 million or 298,367 DOT. 1554 Total views 57 Total shares Calls from the crypto community for Ukraine to accept other cryptocurrencies have been answered. The official Ukraine Twitter account shared that it will now accept […]
Salesforce.com Inc.’s stock CRM, +0.11% rose 0.2% in afternoon trading Tuesday, and was one of just four of 30 Dow Jones Industrial Average DJIA, -2.15% components gaining ground, ahead of the customer-relationship-management software company’s fiscal fourth-quarter results due out after the closing bell. An options strategy known as a straddle is priced for a one-day […]
Shift4 has more than 425 software integrations and over 200,000 merchant customers 490 Total views 14 Total shares According to an investor presentation published Tuesday, U.S.-based payment solutions provider Shift4 announced its acquisition of The Giving Block in cash and stock for $54 million, plus a potential earnout of up to $246 million. The Giving […]
Lennar Corp. LEN, +0.29% disclosed Tuesday that both co-Chief Executives Rick Beckwitt and Jonathan Jaffe had total compensation of $34.045 million in 2021, up from 2020 total comp $21.983 million for Beckwitt and $19.352 million for Jaffe. The combined compensation for both home builder’s CEOs of $68.090 million was up 64.7% from 2020. The salaries […]
1,817 crypto ATMs have been installed worldwide in the first two months of 2022. Last year saw 2,435 crypto ATMs installations in the same time window. 3315 Total views 31 Total shares Over the last six months, Bitcoin (BTC) recorded numerous milestones — El Salvador’s mainstream adoption, a new all-time high of $69,000 and a […]
Shares of Gilead Sciences Inc. GILD, +0.07% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response letter from the Food and Drug Administration regarding its application for an experimental HIV drug. Gilead is seeking FDA approval for lenacapavir, a long-acting HIV-1 capsid inhibitor, for people with multi-drug […]